Analyst Ratings for Dianthus Therapeutics (DNTH)
DNTH Rating Summary
DNTH Price Target Summary
- Highest: $200.00 (Guggenheim)
- Lowest: $44.00 (Wedbush)
- Average: $129.15
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$129.15 (+25.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/4/2026 | Citi | Samantha Semenkow | New Coverage | Buy (N/A) |
156.00 (N/A) |
107.85 (103.28) |
-4.24% | Details |
| 4/8/2026 | Wolfe Research » Updated 6/10/2026 |
Andy Chen | New Coverage | Outperform (N/A) |
98.00 (N/A) |
86.20 (103.28) |
19.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
